Emergent Biosolutions CEO Robert Kramer told CNBC Monday it is uncertain that a coronavirus vaccine can be available by the end of the year to fulfill President Donald Trump’s wishes.
The specialty biopharmaceutical company is collaborating with drug giant Johnson & Johnson on a Covid-19 vaccine candidate, which Johnson & Johnson hopes will receive emergency use authorization in 2021.
“Nobody can guarantee anything,” Kramer said in a “Mad Money” interview with Jim Cramer. “We’re here, as well as all of our partners and collaborators, doing everything we can to make sure that a vaccine and treatments are available as soon as possible.”
Image: https://www.cnbc.com
